Akorn receives FDA approval for fluticasone propionate nasal spray USP, 50 mcg per spray
Akorn announced that it received a new ANDA approval from the FDA for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray. Fluticasone propionate nasal spray USP, 50 mcg per spray is indicated for temporary relief of hay fever and other upper respiratory allergies. April 18, 2019